Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma

Detalles Bibliográficos
Autores principales: Pietrobono, Silvia, Stecca, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2023
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219654/
https://www.ncbi.nlm.nih.gov/pubmed/37235835
http://dx.doi.org/10.18632/oncotarget.28441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219654/
https://www.ncbi.nlm.nih.gov/pubmed/37235835
http://dx.doi.org/10.18632/oncotarget.28441

Ejemplares similares